| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8786236 | Clinical Oncology | 2018 | 7 Pages |
Abstract
Although VMAT decreases the dose delivered to the small bowel, this does not translate into a reduction in patient-reported toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K.L. White, E. Varrassi, J.A. Routledge, L.H. Barraclough, J.E. Livsey, J. McLaughlin, S.E. Davidson,